Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Scientists Found A Switch Drives Alzheimer’s And Turned It Off

Scientists at Heidelberg University in Germany believe they have identified a hidden mechanism deep inside the Alzheimer’s-affected brain that may be one of the primary drivers of the disease, and they have found a compound that can switch it off. The research centers on two proteins that under normal conditions operate independently and serve healthy functions in the brain. But in Alzheimer’s, the two proteins begin pairing in a destructive way that researchers now call a death complex, a combination that damages and kills nerve cells, causes memory loss, and also appears to drive the buildup of amyloid deposits, the protein accumulation long considered one of the hallmarks of the disease. Levels of this harmful pairing were found to be significantly higher in Alzheimer’s mice than in healthy ones, pointing directly at the complex as a meaningful target.

The team developed and tested a compound called FP802 designed to break apart this toxic protein bond at the precise point where the two proteins connect. In mouse experiments, the treatment markedly slowed disease progression, protected synapses from structural damage, preserved the function of the tiny cellular engines that power brain cells, and kept learning and memory abilities largely intact. Perhaps most surprisingly, treated mice also showed a significant drop in amyloid buildup, suggesting the compound does not just address downstream damage but also reduces one of the disease’s most recognized markers. The lead researcher noted that FP802 has also shown protective effects in models of ALS, raising the possibility that this same mechanism plays a role in multiple neurodegenerative diseases. The research team cautions that human clinical trials remain years away and that extensive pharmacological testing is still needed, but the findings, published in Molecular Psychiatry, represent a genuinely new angle of attack on a disease that has resisted effective treatment for decades.

Source: https://www.sciencedaily.com/releases/2026/03/260323005526.htm

PrevPreviousPaid Leave Access Expands To Millions of Americans
NextThe World’s First Quantum Battery Could Change How Everything ChargesNext

Recent Articles

Happy News

She Beat Cancer And Then Adopted A Hawk

March 25, 2026

When the first Covid lockdown arrived, most people tried baking sourdough or following along with an exercise video. Candida Meyrick did something rather more unusual: she adopted a Harris Hawk fledgling, and the decision changed her life in ways she is still discovering. Candida, who had come through breast cancer

Read More
Happy News

Speed-Dating For Friends Is Here: Speed-Friending

March 25, 2026

America is in the middle of what researchers are calling a friendship recession, and the numbers behind it are striking. In 1990, about 3 percent of Americans said they had no friends at all. Today that figure has grown to somewhere between 12 and 20 percent, a shift that scientists

Read More
Happy News

The 2028 LA Olympics Just Revealed Its Official Look

March 24, 2026

The countdown to Los Angeles 2028 just got a lot more colorful. LA28, the organizing committee for the 2028 Summer Olympics, has unveiled the official visual identity for the Games — and it’s a breathtaking love letter to Southern California. Dubbed “LA in Full Bloom,” the design concept is inspired

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.